# San Antonio Breast Cancer Symposium

> **NIH NIH R13** · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2020 · $10,000

## Abstract

The San Antonio Breast Cancer Symposium (SABCS) is a five day international symposium that
provides state-of-the-art information on translational research in breast cancer both for basic
scientists and clinicians who work directly with patients. The symposium's aim is to achieve a
balance of clinical, translational, and basic research, providing a forum for interaction,
communication, and education for a broad spectrum of researchers, health professionals, and
those with a special interest in breast cancer to advance the work of fighting against breast
cancer.
The symposium attracts thought-leaders, academic and private physicians and researchers, as
well as other health care professionals focused on curing breast cancer, to discuss and learn
about new and late-breaking research including experimental biology, etiology, prevention,
diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new
findings from clinical trials. The symposium also attracts young investigators by providing
superior education and training opportunities for the next generation of breast cancer
researchers.
The symposium, now in its thirty-ninth year, is attended by a broad international audience of
academic and private researchers and physicians from over 90 countries with an attendance of
approximately 8,000.
The scientific program consists of plenary lectures and mini-symposia by experts in clinical and
basic research; selected slide and poster presentations chosen from the submitted abstracts;
educational sessions, award lectures, panel and case discussions, a year in review and both
basic science and clinical forums.
The symposium is presented by the Cancer Therapy & Research Center at UT Health Science
Center San Antonio, the American Association for Cancer Research, and Baylor College of
Medicine. The driving force behind this collaboration is the shared mission of the organizations
to advance progress against breast cancer.

## Key facts

- **NIH application ID:** 9993409
- **Project number:** 5R13CA213939-05
- **Recipient organization:** UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- **Principal Investigator:** Virginia Georgia Kaklamani
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $10,000
- **Award type:** 5
- **Project period:** 2016-09-15 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9993409

## Citation

> US National Institutes of Health, RePORTER application 9993409, San Antonio Breast Cancer Symposium (5R13CA213939-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9993409. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*